Parameter Oncovia™ Standard EGFR-TKIs Chemotherapy Progression-Free Survival (PFS) 14.2 months 9.6 months 5.2 months Overall Response Rate (ORR) 75% 56% 37% Severe Side Effects (Grade 3-4) 8% 21% 45% Time to Tumor Reduction 6 weeks 10 weeks 14 weeks Rapid response in lung cancer

Pharma Product Overview - Page 6 Pharma Product Overview Page 5 Page 7